Build a Better Process
Stock Risk Measures for Invitae Corp
A quantitative factor review, as of September 30, 2020.
- Company Info - Description, identity and sector data.
- Share Data - Stock earnings and key dates.
- Market Risk - Beta, size, liquidity and momentum measures.
- Financial Risk - Earnings and dividends.
Updated: October 01, 2020
See how we arrive at an overall risk score of
for NVTA below.
An ad-free and cookie-free webpage by FactorPad
NVTA Risk Report
Our quantitative data points are meant to provide a high-level understanding of
factors in equity risk models for Invitae Corp. Portfolio managers use these
models to forecast risk, optimize portfolios and review performance.
We show how NVTA stock compares to 2,000+ US-based stocks, and to
peers in the Health Services sector and Medical/Nursing Services industry.
Please do not consider this data as investment advice. Data is downloaded from
sources we deem reliable, but errors may occur.
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
- Symbol: NVTA
- FactorPad FPID: f48znm
- SEC CIK: 0001501134
- Share Class FIGI: BBG005DJFD52
- Location: San Francisco, CA US
- Web: http://www.invitae.com
- Employees: 1,300
Sector and Industry
- Sector: Health Services
- Industry: Medical/Nursing Services
- SIC Code: 8071
Shares and Float
- Shares Outstanding: 132,026,000
- Shares Trading: 126,446,317
- Percent Trading: 95.8 %
Earnings and Dividends
- Trailing 12-month earnings: -3.89
- Next earnings date: 2020-11-09
- Dividends in last 12 months: None
- Ex-dividend date: None
Market Risk Measures
Many of the following risk metrics are standardized and transformed into
quantitative factors in institutional-level risk models.
Rankings below represent percentiles from 1 to 100, with 1 being the lowest
rating of risk.
Stocks with higher beta exhibit higher sensitivity to the ups and downs
in the market. (↑↑)
Beta: 1.71 |
Stocks with higher market capitalization often have lower risk. (↑↓)
Market Capitalization: $5,723,327,100 |
Higher average daily dollar volume over the past 30 days implies lower
liquidity risk. (↑↓)
Daily Dollar Volume: $128,432,345 |
Higher price momentum stocks, aka recent winners, equate to lower risk for many
Stock Price Change (1-Year): 137.79% |
Financial Risk Measures
Style risk factors often include measures of profitability and payout levels.
Companies with higher earnings generally provide lower risk. (↑↓)
Earnings Yield (E/P): -8.84% |
Companies with higher dividend yields, if sustaintable, are perceived to
have lower risk. (↑↓)
Dividend Yield (D/P): 0% |
NVTA stock risk
INVITAE CORP stock beta
NVTA risk report
NVTA risk analysis
INVITAE CORP credit risk
NVTA liquidity risk
NVTA systematic risk
NVTA specific risk
INVITAE CORP volatility
NVTA financial ratio
This is a new resource, spread the word, tell a friend